Form D · Biotechnology
Medical Engineering Partners LLC
Detroit, MI · CIK 0001656306
Offering snapshot reported Oct 30, 2015 · SEC filing
- Reported sold
- $250K Offering amount: $1M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 20, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2015 | Initial | $250,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250440
Source: Form D, filed Oct 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Auner | Director, Executive |
| David Ellis | Director |
| Edson Pontes | Director |
| Charles Shanley | Executive |
| Mark Trexler | Director, Executive |
| Donald Weaver | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1406 Gratiot Ave
Detroit, MI, 48230
Detroit, MI, 48230